Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
A pilot program found that Medicare beneficiaries were 57 percent less likely to receive prescriptions that may cause potential health risks through the use of electronic prior authorization (ePA).
The Centers for Medicare & Medicaid Services (CMS) published a request for information on Nov. 20 asking healthcare providers for their assistance in designing and developing a survey on patient and family experiences with inpatient rehabilitation facilities.
The U.S. Department of Agriculture is investing $23.4 million in 75 projects across 31 states and the Western Pacific to expand distance learning and telemedicine in rural areas.
The sixth most popular EHR vendor announced the ability of its customers to use CommonWell Health Alliance services to exchange clinical information from its system with other alliance participants at no cost.
KLAS published its inaugural market report on value-based care (VBC) this week, surveying more than 100 healthcare executives about the impact of hiring VBC firms for consultations or managed-care services.
Lucro is a new marketplace that aims to accelerate decision-making for healthcare leaders, helping them discover, compare and collaborate with peers around innovative solutions.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.